Pengana Equities (ASX: PIA) — Company Overview, News & Financial Data
Pengana Equities is an Australian fund manager offering Australian equity funds with a focus on high-quality companies.
Pengana Equities
Pengana Equities is an Australian listed investment company that provides investors with access to an actively managed, ethically screened portfolio of international equities. The company aims to generate long-term capital growth and deliver regular, reliable, fully franked dividend distributions to its shareholders. Its investment strategy utilizes a comprehensive negative screening framework to exclude companies with material revenue derived from sectors deemed unethical, such as weapons, tobacco, or fossil fuels. The portfolio consists of global equities across diverse sectors, including technology, healthcare, and consumer goods, managed with a focus on business quality, financial strength, and sustainable competitive advantages.
Snapshot
Operations
Products and/or services of Pengana Equities
- Core International Equities Portfolio: Allocation of capital into a diversified portfolio of 35 to 75 global companies across developed and emerging markets, targeting long-term capital growth through investments in high-quality public companies such as Alphabet, Amazon, and Microsoft.
- Ethical and ESG Negative Screening: Implementation of negative screening criteria to exclude companies deriving material operating revenues from unethical sectors, including weapons, tobacco, gambling, nuclear power, thermal coal, and direct environmental damage across all investment allocations.
- Fully Franked Dividend Distribution: Quarterly distribution of franked dividends to shareholders derived from underlying portfolio income and realized capital gains, supported by profit reserves maintained to preserve dividend consistency across varying market cycles.
- Global Small and Mid-Cap Equities Management: Active management of international small and mid-capitalization equity strategies designed to capture growth opportunities in emerging global market leaders while maintaining strict risk management and fundamental business evaluation protocols.
- Healthcare and Pharmaceuticals Allocation: Strategic portfolio positioning in global healthcare and pharmaceutical companies, including holdings in AbbVie, AstraZeneca, Johnson & Johnson, and Roche, focusing on durable earnings streams and medical technology innovations.
- Technology and Semiconductor Investments: Direct capital deployment into global technology and semiconductor infrastructure providers, including holdings in NVIDIA, Taiwan Semiconductor Manufacturing Company, ASML, and Broadcom, targeting structural demand in digital computing and software.
Pengana Equities executive team
- Mr. David Barclay Buckland B.Com., F.Fin, FCIS, FCPA, M. App.FinExecutive Director
- Ms. Paula Cristina Ferrao B.BusCFO of Hunter Hall International Ltd and COO of Hunter Hall International Ltd
- Mr. David Michael Deverall A.M.Chief Executive Officer of Hunter Hall International Limited
- Mr. James Fisher McDonald B.Com., L.L.B.Portfolio Manager